STOK Stoke Therapeutics Q4 2025 EPS misses estimates by 333 pushing shares 258 lower in todays session CRACU CrownReserve releases latest quarterly earnings updates investors on ongoing SPAC acquisition search efforts Synergy CHC SNYR Stock Why Funds Watch It Quiet 20260427